Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QAX576 for Post-shave Keloid Recurrence
NCT00987545Phase 2Terminated
- Sponsor
- Novartis
- Start
- Jun 2009
- Primary completion
- Nov 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of dectrekumab in keloid, sponsored by Novartis. Started Jun 2009; status: terminated.
02
Drugs
dectrekumab
03
Conditions
keloid
Beyond the preview
Go deeper on NCT00987545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00987545.